Bioadhesive matrix as controlled release dosage form for verapamil hydrochloride: Effect of mixing polymers on water uptake of the matrix and the drug release rate using simplex lattice design

Pharmazeutische Industrie

Volumn 61, Issue 7, 1999, Pages 666-670

  Elkheshen, Seham A ^a   Hosny, Ehab A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Bioadhesive matrix; Controlled release preparations; Hydrophilic polymers; Simplex lattice design; Verapamil hydrochloride; Water uptake

Indexed keywords

ADHESIVE AGENT; MICROCRYSTALLINE CELLULOSE; POLYMER; VERAPAMIL;

ARTICLE; CONTROLLED RELEASE FORMULATION; PHARMACEUTICAL ENGINEERING; TABLET COMPRESSION; TENSILE STRENGTH; WATER TRANSPORT;

EID: 0032856862     PISSN: 0031711X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kohlhardt, M., Bauer, B., Krause, H. et al., Experimenta 28, 288 (1972)
2. Singh, B., Ellrodt, G., Peter, C. T., Drugs 15, 169 (1978)
3. Eichelbaum, M., Ende, M., Remberg, G. et al., Eur. J. Clin. pharmacol. 19, 133 (1981)
4. Gibbs, J. S., McAlpine, H. M., Wright, C. et al., Int. J. Cardiol. 31, 281 (1991)
5. Gradman, A. H., Frishman, W. H., Kaihlanen, P. M. et al., Am. J. Cardiol. 70, 1571 (1992)
6. Ch'ng, H. S., Park, H., Kelly, P. et al., J. Pharm. Sci. 74, 399 (1985)
7. Junginger, H. E., Lehr, C. M., Bouwstra, J. A., Drug News Perspectives 3, 352 (1990)
8. Chitnis, V. S., Malshe, V. S., Lalla, J. K., Drug Dev. Ind. Pharm. 17, 879 (1991)
9. Vigoreaux, V., Ghaly, E. S., Drug Dev. Ind. Pharm. 20, 2519 (1994)
10. Hosny, E. A., Int. J. Pharm. 133, 149 (1996)
11. Ishida, M., Machida, Y., Nambu, N. et al., Chem. Pharm. Bull. 29, 810 (1981)
12. Gurny, R., Meyer, J., Peppas, N. A., Biomaterials 5, 336 (1984)
13. Warren, S. L., Kellaway, I. W., Timmins, P., Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 16, 402 (1989)
14. Davies, N. M., Farr, S. J., Hadgraft, J. et al., Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 16, 103 (1989)
15. Gurtler, F., Kaltsatos, V., Boisrame, B. et al., Pharm. Res. 12, 1791 (1995)
16. Walsh, D. S., Dunn, C. L., Konzelman, J. et al., Arch. Dermatol. 131, 265 (1995)
17. Hosny, E. A., Niazy, E. M., El-Gorashi, A. S., Int. J. Pharm. 117, 147 (1995)
18. Hosny, E. A., Niazy, E. M., El-Dardari, M. M., Int. J. Pharm. 136, 37 (1996)
19. Smart, J. D., Kellaway, I. W., Worthington, H. E. C., J. Pharm. Pharmacol. 36, 295 (1984)
20. Leung, S. S., Robinson, J. R., J. Controlled Release 5, 223 (1988)
21. Lehr, C., Bouwstra, J. A., Schacht, E. H. et al., Int. J. Pharm. 78, 43 (1992)
22. Park, K., Robinson, J. R., Int. J. Pharm. 19, 107 (1984)
23. Ponchel, G., Touchard, F., Duchêne, D. et al., J. Controlled Release 5, 129 (1987)
24. Lejoyeux, F., Ponchel, G., Wouessidjewe, D. et al., Drug Dev. Ind. Pharm. 15, 2037 (1989)
25. Duchene, D., Touchard, F., Peppas, N. A., Drug Dev. Ind. Pharm. 14, 283 (1988)
26. Mikos, A. G., Peppas, N. A., S. T. P. Pharma 2, 705 (1986)
27. Sheth, P. R., Tossounian, J., Drug Dev. Ind. Pharm. 10, 313 (1984)
28. Bolton, S., Pharmaceutical Statistics, practical and clinical applications, 2nd. ed., p. 553, Marcel Dekker, New York-Basel (1990)
29. Elkheshen, S., J. Microencapsulation 13, 447 (1996)
30. Celik, M., Compaction of multiparticulate oral dosage forms in: L. Ghebresellasie (ed.), Multiparticualte Oral Drug Delivery, pp. 181-215, Marcel Dekker, New York-Basel (1994)
31. Peppas, N. A., Pharm. Acta Helv. 60, 110 (1985)
32. Rizk, S., Duru, C., Gaudy, D. et al., Drug Dev. Ind. Pharm. 20, 2563 (1994)
33. Ranga Rao, K. V., Padmalatha Devi, K., Buri, P., Drug Dev. Ind. Pharm. 14, 2299 (1988)
34. Hussain, A. S., Johnson, R. D., Shivanand, P. et al., Drug Dev. Ind. Pharm. 20, 2645 (1994)
35. Elkheshen, S., Pharm. Ind. 60, 555 (1998)